Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2B | P41595 | 1/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 1/20 | 1.00 |
| ▸ | NPC1 | O15118 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | AGPAT2 | O15120 | 3/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.47 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | CDK9 | P50750 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Irsogladine SCHEMBL29517870 | 1.00 | HTR2B (1.00) | HTR2BPDE4DNPC1RAB9AAGPAT2 | |
| SCHEMBL8412370 | 0.91 | HTR2B (0.83) | HTR2BPDE4DNPC1RAB9AAGPAT2 | |
| Irsogladine SCHEMBL29518346 | 0.86 | HTR2B (0.73) | HTR2BPDE4DNPC1RAB9AAGPAT2 | |
| Irsogladine SCHEMBL440934 | 0.86 | HTR2B (0.73) | HTR2BPDE4DNPC1RAB9AAGPAT2 | |
| Irsogladine SCHEMBL3308315 | 0.86 | HTR2B (0.73) | HTR2BPDE4DNPC1RAB9AAGPAT2 | |
| Irsogladine SCHEMBL8447523 | 0.86 | HTR2B (0.73) | HTR2BPDE4DNPC1RAB9AAGPAT2 | |
| SCHEMBL8413392 | 0.85 | HTR2B (0.73) | HTR2BPDE4DNPC1RAB9AAGPAT2 | |
| Irsogladine SCHEMBL28287178 | 0.84 | HTR2B (0.71) | HTR2BPDE4DNPC1RAB9AAGPAT2 | |
| SCHEMBL9566485 | 0.84 | HTR2B (0.72) | HTR2BPDE4DNPC1RAB9ARECQL | |
| SCHEMBL9566554 | 0.84 | HTR2B (0.72) | HTR2BPDE4DNPC1RAB9AAGPAT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9741 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| US-12478627-B2 | Irsogladine for the treatment of eosinophilic gastrointestinal diseases | EPITHELION SCIENCE BIOTECH, S.L. (ES) | 2025-11-25 | — | — | US | claimed |
| US-20240343697-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2024-10-17 | — | — | US | claimed |
| US-11903992-B2 | Composition comprising lidocaine, l-carnosine and dexpanthenol | CELLIX BIO PRIVATE LIMITED (IN) | 2024-02-20 | — | — | US | claimed |
| EP-3980020-B1 | IRSOGLADINE FOR THE TREATMENT OF EOSINOPHILIC GASTROINTESTINAL DISEASES | EPITHELION SCIENCE BIOTECH S L (ES) | 2023-08-23 | — | — | EP | claimed |
| WO-2022190030-A1 | A TOPICAL FORMULATION FOR THE TREATMENT OF SKIN DISEASES | AVACA PHARMA PRIVATE LIMITED (IN) | 2022-09-15 | — | — | WO | claimed |
| WO-2022157587-A1 | A COMPOSITION COMPRISING LIDOCAINE, L-CARNOSINE AND DEXPANTHENOL | CELLIX BIO PRIVATE LIMITED (IN) | 2022-07-28 | — | — | WO | claimed |
| US-20220233629-A1 | COMPOSITION COMPRISING LIDOCAINE, L-CARNOSINE AND DEXPANTHENOL | CELLIX BIO PRIVATE LIMITED (IN) | 2022-07-28 | — | — | US | claimed |
| US-20220226333-A1 | IRSOGLADINE FOR THE TREATMENT OF EOSINOPHILIC GASTROINTESTINAL DISEASES | EPITHELION SCIENCE BIOTECH, S.L. (ES) | 2022-07-21 | — | — | US | claimed |
| WO-2000061549-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2000-10-19 | — | — | WO | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-6093748-A | APPLYING TO AN AREA OF SKIN FROM WHICH REDUCED HAIR GROWTH IS DESIRED A DERMATOLOGICALLY ACCEPTABLE COMPOSITION CONTAINING A NON-STEROIDAL SUPPRESSOR OF ANGIOGENESIS | AHLUWALIA GURPREET S (US) | 2000-07-25 | — | — | US | claimed |
| WO-2000010552-A2 | USE OF ANTI-ANGIOGENIC AGENTS FOR INHIBITING VESSEL WALL INJURY | GLOBAL VASCULAR CONCEPTS, INC. (US) | 2000-03-02 | — | — | WO | claimed |
| EP-0812185-A2 | USE OF ANGIOGENESIS SUPPRESSORS FOR INHIBITING HAIR GROWTH | HANDELMAN, Joseph H. (US) | 1997-12-17 | — | — | EP | claimed |
| WO-1996026712-A2 | USE OF ANGIOGENESIS SUPPRESSORS FOR INHIBITING HAIR GROWTH | HANDELMAN, JOSEPH, H. (US) | 1996-09-06 | — | — | WO | claimed |
| US-4657907-A | ANTIULCER AGENT | NIPPON SHINYAKU CO., LTD. (JP) | 1987-04-14 | — | — | US | claimed |
| EP-0114908-B1 | FINELY PULVERIZED 2,4-DIAMINO-6-(2,5-DICHLOROPHENYL)-1,3,5-TRIAZINE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1986-05-21 | — | — | EP | claimed |
| US-4532238-A | Treating peptic ulcers | NIPPON SHINYAKU CO., LTD. (JP) | 1985-07-30 | — | — | US | claimed |
| EP-0114908-A1 | Finely pulverized 2,4-diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine and pharmaceutically acceptable acid addition salts thereof | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1984-08-08 | — | — | EP | claimed |